Most Common Adverse Events Key Observations: Gastrointestinal adverse events are dose-dependent and most pronounced during dose escalation Symptoms typically peak within the first 4-8 weeks and diminish with continued treatment as tolerance develops Slow titration (4-week intervals) significantly reduces the incidence and severity of GI events Most adverse events classified as mild to moderate in severity [9] Discontinuation Rates 7.3% Placebo discontinuation rate [9] 15.8% Cagrilintide 2.4 mg (optimal dose) [9] 24.5% Cagrilintide 4.5 mg (high dose) [9] The majority of discontinuations due to adverse events occurred during the titration phase, with GI symptoms (nausea, vomiting) being the primary reasons
This product is not intended for human or animal use, clinical applications, diagnostic procedures, or consumption of any kind
Men may notice reduced energy levels, affecting libido and sexual performance
GHK-Cu is a human tripeptide with a wide range of biological effects, including stimulation of collagen production, wound healing, and modulation of gene expression. Pickart & Margolina, Oxidative Medicine and Cellular Longevity How GHK-Cu Works Stimulates Collagen and Elastin Production GHK-Cu promotes the synthesis of collagen, elastin, and glycosaminoglycanskey components of the skins extracellular matrix
For laboratory handling it is typically reconstituted with a compatible solvent such as bacteriostatic water before use in non-clinical assays